Endoscopic Submucosal Dissection Industry Overview
Endoscopic Submucosal Dissection Market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9% according to a new report by MarketsandMarkets™.
Endoscopy is increasingly being used to remove precancerous and cancerous areas in the GI tract. The rising incidence of target diseases such as cancer is expected to accelerate the need for endoscopic procedures, which, in turn, would propel the growth of the endoscopic submucosal dissection market in the coming years. However, the demand for surgeons is steadily increasing, and the supply of future surgeons is not rising at the same rate. Therefore, this shortage will likely reduce the number of yearly ESD procedures.
Gather more insights about the market drivers, restrains and growth of the Endoscopic Submucosal Dissection Market
Based on product, the gastroscopes and colonoscopes segment accounted for the largest share of the global endoscopic submucosal dissection market
Based on product, the endoscopic submucosal dissection market is segmented into knives, tissue retractors, graspers/clips, injection agents, gastroscopes and colonoscopes, and other products. The gastroscopes and colonoscopes segment accounted for the largest share of the global endoscopic submucosal dissection market in 2021. The large share of the gastroscopes and colonoscopes segment can be attributed to the continuous increase in the prevalence of colorectal cancer and the rising demand for minimally invasive procedures
Based on indication, the stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market
Based on indication, the endoscopic submucosal dissection market is segmented into stomach cancer, colon cancer, and esophageal cancer. The stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market in 2021. With the rapid growth in the geriatric population, the prevalence of stomach cancer is also expected to increase in the forecast period, thus resulting in a higher demand for endoscopic submucosal dissection procedures.
Based on end user, the hospital segment is expected to dominate the endoscopic submucosal dissection market
Based on end user, the endoscopic submucosal dissection market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and other end users. The hospital segment is expected to dominate the endoscopic submucosal dissection market during the forecast period. Increasing investments and incentives received by hospitals from government bodies and private investors for endoscopic surgery and instruments further increase the preference for endoscopic surgeries among physicians.
The Asia Pacific market is expected to grow at a higher CAGR during the forecast period
The APAC market is expected to grow at the highest rate during the forecast period. Factors such as the growing number of hospitals, improving healthcare infrastructure, increasing healthcare expenditure, growing patient population, and surging demand for minimally invasive surgeries are boosting the growth of the endoscopic submucosal dissection market in the Asia Pacific.
Endoscopic Submucosal Dissection Market Segmentation
This report categorizes the global endoscopic submucosal dissection market into the following segments and subsegments:
By Product
- Gastroscopes And Colonoscopes
- Knives
- Injection Agents
- Tissue Retractors
- Graspers/Clips
- Other Products
By Indication
- Stomach Cancer
- Colon Cancer
- Esophageal Cancer
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Share Insights
- In March 2021, FUJIFILM Holdings Corporation (Japan) acquired Diagnostic Imaging-related Business (the Business), Hitachi, Ltd.. This acquisition helped in the expansion of the medical systems business of FUJIFILM Corporation.
- In January 2021, Olympus Corporation (Japan) acquired Quest Innovations B.V. (Netherlands). The acquisition enabled Olympus to strengthen its surgical endoscopy capabilities and incorporate Quest’s advanced FIS capabilities into its comprehensive medical imaging portfolio.
Order a free sample PDF of the Endoscopic Submucosal Dissection Market Intelligence Study, published by MarketsandMarkets
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
